4.6 Review

Challenges associated with the identification of germline variants on myeloid malignancy genomic profiling-a Singaporean experience

期刊

FRONTIERS IN ONCOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2023.1182639

关键词

myeloid neoplasm; genetic counselling; gene variants; germline variants; incidental findings

类别

向作者/读者索取更多资源

Genomic profiling for myeloid malignancies is a routine procedure that can identify gene mutations, including both somatic and germline variants. While germline variants are primarily intended for identification of somatic mutations, occasionally, clinically significant germline variants are also identified. This article discusses challenging cases where germline variants were found in genes not associated with the patient's phenotype, and the genetic counseling and management approaches in these situations.
Genomic profiling to identify myeloid-malignancy-related gene mutations is routinely performed for patients with suspected or definite myeloid malignancies. The most common specimen types in our experience are peripheral blood and bone marrow aspirates. Although primarily intended to identify somatic mutations, not infrequently, potentially clinically significant germline variants are also identified. Confirmation of the germline status of these variants is typically performed by hair follicle or skin fibroblast testing. If the germline variant is classified as a pathogenic or likely pathogenic variant and occurs in a gene known to be associated with a disease relevant to the patient's phenotype (for example, the identification of a DDX41 pathogenic variant in an individual with acute myeloid leukemia), the management algorithm is typically quite straightforward. Challenging situations may occur such as when the germline variant is classified as a pathogenic or likely pathogenic variant and occurs in a gene not known to be associated with the patient's phenotype/presenting complaint. We have encountered several such challenging cases in which potentially clinically significant germline variants were identified on the initial genomic profiling of peripheral blood or bone marrow aspirate. In this article, we present these cases and discuss the genetic counseling and management approaches.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据